Methylation of MGMT and hMLH1 in Liver Cancer Linked to Hepatitis
Author Information
Author(s): Matsukura S, Soejima H, Nakagawachi T, Yakushiji H, Ogawa A, Fukuhara M, Miyazaki K, Nakabeppu Y, Sekiguchi M, Mukai T
Primary Institution: Saga Medical School
Hypothesis
The study investigates the relationship between CpG methylation of MGMT and hMLH1 promoters and hepatocellular carcinoma associated with hepatitis viral infection.
Conclusion
The study found that a significant number of hepatocellular carcinoma cases exhibited methylation of the MGMT and hMLH1 promoters, which may be linked to hepatitis viral infections.
Supporting Evidence
- 46 hepatocellular carcinoma samples were analyzed for methylation status.
- 28 out of 46 tumors were MGMT-negative, and 10 out of 46 were hMLH1-negative.
- Hypermethylation of MGMT was associated with hepatitis viral infection.
- Statistical analysis showed significant differences in methylation frequency between cancerous and normal tissues.
Takeaway
This study looked at liver cancer and found that some cancer cells had changes in their DNA that might be caused by hepatitis viruses.
Methodology
The study involved analyzing tissue specimens from patients with hepatocellular carcinoma and assessing the methylation status of MGMT and hMLH1 promoters using urea/bisulphite sequencing.
Limitations
The study did not use microdissection methods, which may affect the accuracy of the methylation analysis due to the presence of non-tumor DNA.
Participant Demographics
Mean age 63.8 years; 35 males and 11 females; 7 HBV positives, 33 HCV positives, 1 HBV/HCV positive, and 5 HBV/HCV negatives.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website